MELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis Review

Date: July 21, 2015
Pages: 50
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M7CF9D9DC8CEN
Leaflet:

Download PDF Leaflet

MELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis Review
MELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

MELA Sciences, Inc. (MELA Sciences), formerly Electro-Optical Sciences, Inc., is a medical device company. It designs, develops and commercializes non-invasive tools that aid dermatologists in the detection of melanoma. The company’s lead product MelaFind is a non-invasive point-of-care instrument that enables the detection of melanoma. It features a hand-held imager that captures digital data from clinically atypical pigmented skin lesions. The data collected is analyzed on the company's proprietary database of melanomas and benign lesions that provide information to assist in the management of the patient’s disease, including information useful in deciding whether to biopsy the lesion. The company received CE mark and Pre-Market Approval (PMA) from the US FDA for MelaFind. MELA Sciences is headquartered in New York, the US.

MELA Sciences, Inc. Key Recent Developments

May 14, 2015: MELA Sciences Reports First Quarter 2015 Financial Results
Mar 30, 2015: MELA Sciences Reports 2014 Financial Results and Provides a Business Update
Nov 06, 2013: MELA Sciences reports third quarter 2013 results and launch of new strategic plan
Nov 06, 2013: MELA Sciences Appoints Rose Crane as President and Chief Executive Officer and a Director, Effective as of Monday, November 11th
Oct 25, 2013: MELA Sciences, a Leader in the Fight Against Melanoma, Participates in the Washington D.C. Dermatological Society's Fall Clinical Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

MELA Sciences, Inc. - Key Facts
MELA Sciences, Inc. - Key Employees
MELA Sciences, Inc. - Key Employee Biographies
MELA Sciences, Inc. - Major Products and Services
MELA Sciences, Inc. - Medical Equipment Pipeline Products Data
MELA Sciences, Inc. Pipeline Products by Equipment Type
MELA Sciences, Inc. Pipeline Products by Development Stage
MELA Sciences, Inc. - History
MELA Sciences, Inc. - Company Statement
MELA Sciences, Inc. - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

MELA Sciences, Inc. - Business Description
MELA Sciences, Inc. - Corporate Strategy
MELA Sciences, Inc. - SWOT Analysis
SWOT Analysis - Overview
MELA Sciences, Inc. - Strengths
Strength - Agreements and Alliances
Strength - Research and Development
Strength - Flagship Product: MelaFind
Strength - Improving Cash Reserves
MELA Sciences, Inc. - Weaknesses
Weakness - History of Losses
Weakness - Dependence on Third Party Sources
MELA Sciences, Inc. - Opportunities
Opportunity - Market Opportunity
Opportunity - Acquisition of XTRAC and VTRAC Dermatology Business
Opportunity - Changing Demographics
MELA Sciences, Inc. - Threats
Threat - Stiff Competition
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
MELA Sciences, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

MELA Sciences, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
MELA Sciences, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
MELA Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
MELA Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
MELA Sciences, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 14, 2015: MELA Sciences Reports First Quarter 2015 Financial Results
Mar 30, 2015: MELA Sciences Reports 2014 Financial Results and Provides a Business Update
Nov 19, 2014: MELA Sciences Names Michael R. Stewart Its Next President and CEO
Nov 12, 2014: MELA Sciences Reports Third Quarter 2014 Financial Results
Oct 21, 2014: Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in Patients at Risk for Melanoma
Sep 15, 2014: MELA Sciences to Provide Corporate Overview at the Craig-Hallum Capital Group's 2014 Alpha Select Conference
Aug 26, 2014: MELA Sciences Collaborates With Columbia University Imaging Experts
Aug 13, 2014: MELA Sciences Reports Second Quarter 2014 Financial Results and Provides a Business Update
Aug 05, 2014: MELA Sciences Names Michael R. Stewart to Board of Directors
Jul 29, 2014: MELA Sciences Regains Compliance With NASDAQ Listing Requirements

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

MELA Sciences, Inc., Key Facts
MELA Sciences, Inc., Key Employees
MELA Sciences, Inc., Key Employee Biographies
MELA Sciences, Inc., Major Products and Services
MELA Sciences, Inc. Number of Pipeline Products by Equipment Type
MELA Sciences, Inc. Pipeline Products by Equipment Type
MELA Sciences, Inc. Number of Pipeline Products by Development Stage
MELA Sciences, Inc. Pipeline Products by Development Stage
MELA Sciences, Inc., History
MELA Sciences, Inc., Key Competitors
MELA Sciences, Inc., Ratios based on current share price
MELA Sciences, Inc., Annual Ratios
MELA Sciences, Inc., Interim Ratios
MELA Sciences, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
MELA Sciences, Inc., Medical Equipment, Deals By Type, 2009 to YTD 2015
MELA Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
MELA Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015
MELA Sciences, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

MELA Sciences, Inc. Pipeline Products by Equipment Type
MELA Sciences, Inc. Pipeline Products by Development Stage
MELA Sciences, Inc., Performance Chart (2010 - 2014)
MELA Sciences, Inc., Ratio Charts
MELA Sciences, Inc., Medical Equipment, Deals By Year, 2009 to YTD 2015
MELA Sciences, Inc., Medical Equipment, Deals by Type, 2009 to YTD 2015
MELA Sciences, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
MELA Sciences, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Skip to top


Ask Your Question

MELA Sciences, Inc. (MELA) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: